


Although federal health regulators are concerned that a new Medtronic spine-stabilizing device may increase cancer risks for some patients, the Orthopedic and Rehabilitation Devices Panel of the U.S. Food and Drug Administrations (FDAs) Medical Devices Advisory Committee just voted to endorse approval of the device, wrote MedScape. There is one catch, however, Medtronic must conduct follow-up ...
Read more...Johnson closer to rehab stint for Dodgers
Read more...Pitching becomes trade focus for LA
Read more...